Monopar Therapeutics Inc. (MNPR) vs MapLight Therapeutics, Inc. (MPLT)

Monopar Therapeutics Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. Monopar Therapeutics Inc. and MapLight Therapeutics, Inc. are of similar size ($602.8M and $587.7M). Across the 9 metrics below, Monopar Therapeutics Inc. leads on 6 and MapLight Therapeutics, Inc. on 3.

Valuation

Metric MNPR MPLT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 5.56 1.36 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (2.55%) (404.49%) (28.84%)
Free cash flow yield (1.67%) (36.85%) (23.03%)

Profitability

Metric MNPR MPLT Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (19.50%) (297.18%) (57.72%)
Return on assets (18.90%) (124.79%) (49.22%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric MNPR MPLT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 54.99% 82.39% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MNPR MPLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.56 16.52 4.73
Net debt to EBITDA 8.06 1.79 0.96

Dividend

Metric MNPR MPLT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric MNPR MPLT Biotechnology median
Market cap 602.75m 587.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack